Merit Medical Systems, Inc. $MMSI Shares Bought by Diversified Trust Co.

Diversified Trust Co. boosted its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 62.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 22,587 shares of the medical instruments supplier’s stock after purchasing an additional 8,679 shares during the period. Diversified Trust Co.’s holdings in Merit Medical Systems were worth $1,991,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Tudor Investment Corp ET AL purchased a new stake in shares of Merit Medical Systems during the third quarter valued at $2,913,050,000. Assenagon Asset Management S.A. acquired a new position in shares of Merit Medical Systems in the 3rd quarter valued at $1,644,000. Norges Bank purchased a new position in Merit Medical Systems in the 2nd quarter worth $53,697,000. Fort Washington Investment Advisors Inc. OH raised its stake in Merit Medical Systems by 69.7% in the 3rd quarter. Fort Washington Investment Advisors Inc. OH now owns 301,718 shares of the medical instruments supplier’s stock worth $25,112,000 after acquiring an additional 123,912 shares during the last quarter. Finally, Westwood Holdings Group Inc. lifted its position in Merit Medical Systems by 11.9% during the 2nd quarter. Westwood Holdings Group Inc. now owns 768,970 shares of the medical instruments supplier’s stock worth $71,883,000 after acquiring an additional 81,469 shares during the period. Institutional investors and hedge funds own 99.66% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on MMSI shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Merit Medical Systems in a research note on Monday, December 29th. Wells Fargo & Company downgraded shares of Merit Medical Systems from an “overweight” rating to an “equal weight” rating and cut their price target for the stock from $95.00 to $78.00 in a report on Thursday, February 26th. Canaccord Genuity Group lifted their price objective on shares of Merit Medical Systems from $93.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, December 17th. Needham & Company LLC reduced their target price on shares of Merit Medical Systems from $108.00 to $101.00 and set a “buy” rating for the company in a report on Wednesday, February 25th. Finally, BTIG Research assumed coverage on shares of Merit Medical Systems in a report on Friday, February 6th. They issued a “buy” rating and a $107.00 price target on the stock. Eight research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Merit Medical Systems currently has an average rating of “Moderate Buy” and a consensus target price of $103.33.

Merit Medical Systems Price Performance

Shares of NASDAQ MMSI opened at $68.11 on Thursday. The stock has a market capitalization of $4.05 billion, a price-to-earnings ratio of 32.13, a PEG ratio of 1.95 and a beta of 0.62. Merit Medical Systems, Inc. has a 12 month low of $66.34 and a 12 month high of $107.27. The firm’s 50 day simple moving average is $77.34 and its 200-day simple moving average is $82.54. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.34 and a quick ratio of 2.95.

Merit Medical Systems (NASDAQ:MMSI) last posted its earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.08. The firm had revenue of $393.94 million during the quarter, compared to analysts’ expectations of $390.77 million. Merit Medical Systems had a net margin of 8.48% and a return on equity of 13.82%. The business’s revenue was up 10.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.93 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Analysts expect that Merit Medical Systems, Inc. will post 3.37 EPS for the current year.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.